^
BIOMARKER:
HRD + BRCA2 mutation
i
Other names: BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset, HRD, Homologous Recombination Deficiency
Entrez ID:
Related biomarkers:
›
HRD + BRCA2 mutation
|
Prostate Cancer
|
HRD + BRCA2 mutation
|
Prostate Cancer
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|
HRD + BRCA2 mutation
|
Ovarian Cancer
|
HRD + BRCA2 mutation
|
Ovarian Cancer
|
niraparib Sensitive: C3 – Early Trials
|
niraparib Sensitive: C3 – Early Trials
|
HRD + BRCA2 mutation
|
Fallopian Tube Cancer
|
HRD + BRCA2 mutation
|
Fallopian Tube Cancer
|
niraparib Sensitive: C3 – Early Trials
|
niraparib Sensitive: C3 – Early Trials
|
HRD + BRCA2 mutation
|
Peritoneal Cancer
|
HRD + BRCA2 mutation
|
Peritoneal Cancer
|
niraparib Sensitive: C3 – Early Trials
|
niraparib Sensitive: C3 – Early Trials
|
